Log in to MyACC
The management of atrial fibrillation (AFib) and peripheral artery disease (PAD) has become increasingly complex due to the introduction and intersection of direct oral anticoagulants and antithrombotic therapies used to reduce the risk of stroke particularly in patients who are at high or very high risk of stroke (CHADS2VASC2 ≥ 2).
The goals of this solution set are to close gaps in care related to:
- The use of anticoagulants and antithrombotic therapies in patients with CHADS2VASC2 ≥ 2.
- Accessibility of anticoagulants and antithrombotic therapies for eligible patients.
Expert Consensus Decision Pathways
Clinician Tools
- Anticoagulation Shared Decision Making Tool
- Use these handouts to explain anticoagulation options if your patient is living with atrial fibrillation and has:
- Stroke and Bleeding Risk Calculator
- ManageAnticoag
- Considerations for Anticoagulation Reversal / Hemostasis
- AnticoagEvaluator
CardioSmart Patient Tools
Atrial Fibrillation
- What is AFib? (infographic)
- Atrial Fibrillation Medications That Control Rhythm (infographic)
- Atrial Fibrillation Medications That Slow Heart Rate (infographic)
- Atrial Fibrillation and Lowering Stroke Risk (infographic)
- AFib Stroke and Bleeding Risk Calculator (interactive tool)
- Your Action Plan for Managing AFib
- AFib Medication List (worksheet)
- Keeping Track of Symptoms and How AFib Affects Your Life (worksheet)
- AFib Symptom Diary (worksheet)
- 10 Steps You Can Take to Manage Atrial Fibrillation (handout)
Peripheral Artery Disease
- Peripheral Artery Disease (infographic)
- Talking With Patients About PAD (discussion guide)
- Could I have artery disease in my legs? (worksheet)
- What comes next? Managing PAD and other risks (worksheet)
- What is PAD? (handout)
- Understanding PAD (handout)
- Power of exercise (handout)
- Common questions about PAD (handout)
Heart House Roundtables
- Ongoing Dilemmas with Surveillance and Diagnosis of Atrial Fibrillation (2022)
- Antithrombotic Therapy for the Management of PAD and CAD (2018)
- Anticoagulation Consortium (2013-2017)
